ReviewMolecular neurobiology2026
Pathological Priming and Developmental Heterochrony as Organizing Concepts in Human iPSC Models of Autism Spectrum Disorder.
Review in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition in which diverse genetic risk factors converge on molecular pathways governing early brain development. Human-induced pluripotent stem cell (iPSC) and brain organoid models now permit direct interrogation of these pathways in patient-derived neural tissue and, in a subset of studies, reveal alterations in neural progenitor proliferation, cortical neurogenesis, synaptic maturation, and network excitability. A landmark iPSC study in macrocephalic idiopathic ASD introduced the concept of pathological priming of neural progenitors, durable reconfiguration of chromatin and transcriptional states that biases downstream developmental programs, and associated developmental heterochrony in neuronal gene networks, thereby linking early progenitor biology to selectively shifted trajectories of neuronal maturation and to macrostructural and functional abnormalities. This conceptual review synthesizes evidence for pathological priming and developmental heterochrony from human iPSC-derived neurons and brain organoids, focusing on the ASD subgroups in which timing mechanisms are best supported: macrocephalic idiopathic ASD, 16p11.2 and related copy number variants, and large-effect developmental regulators such as SYNGAP1. We summarize recurrent and inconsistent cellular and circuit phenotypes, evaluate multi-omic data implicating progenitor regulatory states in shaping developmental timing, and situate timing-focused mechanisms alongside synaptopathy, excitatory-inhibitory imbalance, critical-period, and neuroimmune models. We propose that disturbances in neurodevelopmental timing characterize specific ASD subgroups, particularly those with early brain overgrowth or large-effect developmental regulators, rather than ASD as a whole, and offer a useful organizing principle for integrating divergent findings and generating testable, timing-informed hypotheses for future experimental and translational work.
Indexed as
Identifiers
42842117What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.